rate

Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody iSCIB1+

July 22, 2025 02:00 ET  | Source: Scancell Holdings Plc SCOPE trial of SCIB1/iSCIB1+ plus standard of care shows excellent…

4 days ago

UnionPay Launches Global Summer Campaign with Exclusive Travel Offers

Exclusive discounts, cashback, and exchange rate perks for international travelers SHANGHAI, July 18, 2025 /PRNewswire/ -- UnionPay International has officially…

1 week ago

OMD TOPS GLOBAL MEDIA AGENCY RANKING

Omnicom Media Group Agency Outperforms the Industry for Billings Volume and Net Growth NEW YORK, July 14, 2025 /PRNewswire/ -- In…

2 weeks ago

India’s Urban Population to Reach 600 Million by 2036: Primus Partners Report

Urbanization on the Rise: India's urbanization rate, which stood at 31% in 2011, is expected to hit 40% by 2036,…

2 weeks ago

Tirupati, India, Among Asia’s Most Affordable Summer Destinations in 2025: Agoda

Digital travel platform Agoda has revealed its list of the most budget-friendly summer destinations in Asia for June to August…

2 weeks ago

CoinDesk Overnight Rates (CDOR) to Support Stablecoin Money Markets based on Aave

These first-of-kind money market rates transform Aave pool activity into conventional overnight rates to support interest rate derivatives and floating…

1 month ago

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with…

1 month ago

Investigational combination of first-in-class bispecific antibodies TALVEY (talquetamab) and TECVAYLI (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate through dual targeting of…

1 month ago

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes

June 05, 2025 17:35 ET  | Source: DENTSPLY SIRONA Inc. CHARLOTTE, N.C., June 05, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA…

2 months ago